This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Barbara Driver
Vice President
Contact
BarbaraDriver@c178.netOverview
Barbara Driver is a Vice President for Clinical Research. She oversees multiple clinical research projects conducted in domestic and international settings focusing on infectious disease. Driver leads the Clinical Unit within the Clinical Trials Practice working to ensure 趣赢平台 operations comply with good clinical practice (GCP) and other applicable requirements.
Education
- MS, Nursing, Lienhard School of Nursing, Pace University
- BS, Health Science/Biology, State University of New York at Cortland
-
Adams et al. respond to “Stop analyzing ‘despair’ deaths together”
American Journal of Epidemiology
January 2023
R.S. Adams, T.L. Spark, C.A. Hoffmire, J.E. Forster, L.A. Brenner
DOILink for: Adams et al. respond to “Stop analyzing ‘despair’ deaths together” -
Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021–2022 season, VISION Network
Journal of Infectious Diseases
January 2023
M.W. Tenforde, Z.A. Weber, M.B. DeSilva, E. Stenehjem, D.-H. Yang, B. Fireman, M. Gaglani, et al.
DOILink for: Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021–2022 season, VISION Network -
Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predo
71,
Morbidity and Mortality Weekly Report
January 2022
M.G. Thompson, K. Natarajan, S.A. Irving, E.A. Rowley, E.P. Griggs, M. Gaglani, N.P. Klein, et al.
DOILink for: Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predo